USANA Health Sciences (NYSE:USNA - Get Free Report) is anticipated to announce its earnings results after the market closes on Tuesday, February 25th. Analysts expect the company to announce earnings of $0.49 per share and revenue of $208.82 million for the quarter. Individual interested in participating in the company's earnings conference call can do so using this link.
USANA Health Sciences Stock Performance
Shares of NYSE USNA traded down $0.24 during midday trading on Friday, reaching $31.85. 176,102 shares of the company traded hands, compared to its average volume of 134,153. The firm has a market cap of $607.02 million, a PE ratio of 11.25, a PEG ratio of 0.90 and a beta of 0.87. The stock's 50-day simple moving average is $33.81 and its 200-day simple moving average is $36.77. USANA Health Sciences has a 12 month low of $30.13 and a 12 month high of $50.32.
Wall Street Analyst Weigh In
Several analysts have weighed in on the stock. DA Davidson upped their price objective on shares of USANA Health Sciences from $35.00 to $38.00 and gave the stock a "neutral" rating in a research note on Thursday, January 2nd. StockNews.com cut USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a report on Friday, February 14th. Finally, Sidoti lowered shares of USANA Health Sciences from a "strong-buy" rating to a "hold" rating in a report on Tuesday.
Get Our Latest Stock Analysis on USANA Health Sciences
USANA Health Sciences Company Profile
(
Get Free Report)
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Read More
Before you consider USANA Health Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and USANA Health Sciences wasn't on the list.
While USANA Health Sciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
